Clinical Review Testing patients to allow tailored drug treatment BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7487.352 (Published 10 February 2005) Cite this as: BMJ 2005;330:352 Article Related content Metrics Responses Peer review Related articles Clinical Review Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase Published: 10 February 2005; BMJ 330 doi:10.1136/bmj.330.7487.350 Clinical Review Criteria influencing the clinical uptake of pharmacogenomic strategies Published: 17 June 2004; BMJ 328 doi:10.1136/bmj.328.7454.1482 See more Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination BMJ January 15, 2021, 372 n149; DOI: https://doi.org/10.1136/bmj.n149 Covid-19: Government uses lateral flow tests to keep children in schools against regulator’s advice BMJ January 15, 2021, 372 n148; DOI: https://doi.org/10.1136/bmj.n148 Covid-19: Doctors’ leaders call for revised PPE guidance to reflect new variants BMJ January 15, 2021, 372 n146; DOI: https://doi.org/10.1136/bmj.n146 Stanley Henry Curry BMJ January 15, 2021, 372 n112; DOI: https://doi.org/10.1136/bmj.n112 Agnes (“Nan”) Blair BMJ January 15, 2021, 372 n110; DOI: https://doi.org/10.1136/bmj.n110
